Cologuard® test | Exact Sciences
Backed by strong science and robust clinical research in collaboration with Mayo Clinic, Cologuard ® is a stool DNA-based colorectal cancer screening test for average-risk individuals who are 45 or older. Cologuard uses a biomarker panel which analyzes a person’s stool sample for 10 DNA markers, as well as blood in the stool (hemoglobin).
At-Home Colon Cancer Screening Test | Cologuard® Patient Site
Feb 4, 2021 · Cologuard is a noninvasive, effective and affordable at-home colon cancer screening test that requires no prep. We’re the only noninvasive screening test that looks for both abnormal DNA and blood in your stool. The American Cancer Society recommends that you begin screening for colon cancer at age 45 1 – no matter your race, ethnicity, or gender.
Why Did I Get a Cologuard Test in the Mail? | Cologuard Patient …
You may have received a Cologuard ® kit because Exact Sciences partners with insurance companies to send Cologuard kits to members who are due for colon cancer screening. The Cologuard test is an easy-to-use, at home screening test that is …
FDA Approves Exact Sciences’ Cologuard Plus Test
MADISON, Wis., Oct. 4, 2024 -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved the Cologuard Plus™ test, the company’s next …
How to use Cologuard® | Cologuard® Patient Site
When it comes to a noninvasive screening test for colon cancer, we’ve thought of everything to make it as easy as possible. We deliver right to your door with step-by-step instructions, it requires no prep or change to your daily routine, and to top it …
Laboratories | Exact Labs
Cologuard® is an FDA-approved, noninvasive multi-target stool DNA test for colorectal cancer screening. The performance characteristics of Cologuard were established in a prospective, multi-site, point-in time study (NCT01397747) of average risk adults ages 50-84.
Cologuard®: A decade of impact - Exact Sciences
Aug 15, 2024 · Exact Sciences launches the ambitious DeeP-C pivotal trial for its multitarget stool DNA test, which would later be named Cologuard. The young company pulls together, determined to bring an innovative screening solution to patients and health care professionals.
Frequently Asked Questions - Exact Labs
Cologuard is an in vitro diagnostic qualitative screening device that utilizes a multi-target approach to detect DNA and hemoglobin markers associated with colorectal cancer (CRC), as well as pre-malignant colorectal neoplasia.
Exact Sciences Corporation - Next-generation Cologuard Test ...
Jun 20, 2023 · The results show that next-generation Cologuard ® met all study endpoints and improved every top-line metric, including a 30 percent lower false positive rate, when compared to DeeP-C, the FDA registrational trial for Cologuard.
Contact Us | Cologuard® Patient Site
To report suspected Adverse Events or product problems, please contact the Exact Sciences Laboratories Customer Care Center at 1‑844‑870‑8870. You can also contact the US Food and Drug Administration (FDA) directly at 1‑800‑FDA‑1088 or visit www.fda.gov/MedWatch.